Head to head
Corteva vs Nutrien
Side-by-side on the measures that matter, with a plain-English read. Full detail: CTVA · NTR
CTVA
Corteva
7.89-2.83%
1-year price shape — -88% over the period
Quant Rating E · 0/100
vs
NTR
Nutrien
63.84-2.40%
1-year price shape — +20% over the period
Quant Rating D · 62/100
1-year performance, rebased to 100
Nutrien edges it on the scoreable measures. Nutrien has the highest Quant Rating (62); Nutrien has done best over the past year (+20%); Nutrien earns the most per share.
| CTVA | NTR | |
|---|---|---|
| Snapshot | ||
| Sector | -- | Agricultural Inputs |
| Last price | 7.89 | 63.84 |
| Change today | -2.83% | -2.40% |
| 1-year return | -87.6% | +19.8% |
| Market cap | $5.27B | $30.27B |
| 52-week range | 7.82 – 16.31 | 51.96 – 81.36 |
| Valuation | ||
| P/E (TTM) | 6.86 | 13.94 |
| P/E percentile, own 5-yr range | 0th | 40th |
| P/B | 0.21 | 1.18 |
| Dividend yield | 9.13% | 3.44% |
| Profitability & growth | ||
| EPS (TTM) | 1.60 | 4.66 |
| Net profit (TTM) | $1.07B | $2.21B |
| Revenue (TTM) | $17.65B | $28.26B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | -6.1% | +0.9% |
| Gross margin | 49.7% | 30.6% |
| Operating margin | 16.8% | 14.2% |
| Net margin | 4.3% | 7.8% |
| Free cash flow (TTM) | $-149.00M | $2.09B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 24.9% | 76.9% |
| Insider activity (12mo) | 38 buy / 10 sell | 1 buy / 2 sell |
| Short interest (% of float) | 7.6% | 1.8% |
| Analyst consensus | 77% buy / 23% hold (13) | 62% buy / 31% hold / 8% sell (13) |
| Analyst price target | $20 (+153%) | $80 (+25%) |
| StockVane view | ||
| StockVane Quant Rating | E (0) | D (62) |
| Company | ||
| Employees | 21,500 | 25,100 |
| Founded | 1802 | 2017 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.